Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature.
The use of rituximab has been uncommonly associated with delayed pulmonary toxicity. We present a case of interstitial pneumonitis and diffuse alveolar hemorrhage, which represents the second such case reported in the literature.